Author | Lynda Charters; Reviewed by Dr Ramin Khoramnia

Articles

IRISS registry study offers real-world outcomes

Investigators found that a fluocinolone acetonide implant maintained good real-world vision levels in patients with diabetic macular oedema who had good baseline vision.